Fund Holdings — ACORN CAPITAL ADVISORS, LLC

Total Portfolio Value:
$295.13M
Total Bought:
$25.63M
Total Sold:
$55.99M
Net Transaction:
-$30.36M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Terns Pharmaceuticals Inc1,971,2641,746,264-225,000$14.80M$70.55M23.90%+$55.74M
CG Oncology, Inc.(CGON)1,131,5011,131,5010$45.58M$46.98M15.92%+$1.40M
UroGen Pharma Ltd.(URGN)1,259,7491,448,420+188,671$25.13M$33.92M11.49%+$8.79M
Trevi Therapeutics, Inc.(TRVI)2,144,8442,144,8440$19.63M$26.85M9.10%+$7.23M
Puma Biotechnology, Inc.(PBYI)4,131,2994,131,2990$21.94M$24.58M8.33%+$2.64M
Candel Therapeutics, Inc.(CADL)2,580,5172,580,5170$13.16M$14.58M4.94%+$1.42M
Cybin D/B/A Helus Pharma(HELP)734,3941,573,023+838,629$4.31M$12.87M4.36%+$8.56M
Verastem, Inc.(VSTM)779,4981,469,153+689,655$6.88M$11.34M3.84%+$4.46M
Bicara Therapeutics643,382643,3820$10.16M$10.83M3.67%+$669.1K
Protara Therapeutics, Inc.(TARA)1,752,1151,752,1150$7.62M$9.34M3.16%+$1.72M
OnKure Therapeutics, Inc.CL A(OKUR)2,839,6742,839,6740$7.81M$8.24M2.79%+$426.0K
Cardiff Oncology, Inc.(CRDF)1,962,0841,962,0840$4.04M$5.51M1.87%+$1.47M
LeonaBio, Inc.(LONA)0501,739+501,739$0$3.80M1.29%+$3.80M
Jasper Therapeutics, Inc.(JSPR)1,382,6401,786,492+403,852$3.29M$3.27M1.11%-$21.4K
Aura Biosciences, Inc.(AURA)595,744595,7440$3.68M$3.25M1.10%-$434.9K
Whitehawk Therapeutics, Inc.(WHWK)1,139,3631,139,3630$2.16M$2.76M0.93%+$592.5K
BioAtla, Inc.(BCAB)4,835,1114,835,1110$3.34M$2.76M0.93%-$580.2K
Q32 Bio Inc.(QTTB)803,425493,425-310,000$1.59M$1.64M0.56%+$47.4K
X4 Pharmaceuticals, Inc.(XFOR)273,349273,3490$934.9K$1.09M0.37%+$158.5K
Acrivon Therapeutics Inc405,237405,2370$733.5K$976.6K0.33%+$243.1K
Yarrow Bioscience Inc(YARW)586,5721,425-585,147$199.4K$8270.00%-$198.6K
Page 1 of 1
ACORN CAPITAL ADVISORS, LLC — 13F Holdings — Q4 2025 | TickerTrail